EPS Q/Q spoločnosti ProMIS Neurosciences
Aká je hodnota metriky EPS Q/Q spoločnosti ProMIS Neurosciences?
Hodnota metriky EPS Q/Q spoločnosti ProMIS Neurosciences, Inc. je 0.00%
Aká je definícia metriky EPS Q/Q?
Štvrťročný rast EPS (Quarterly EPS growth rate) zo štvrťroku na štvrťrok je nárast EPS spoločnosti za posledné štyri štvrťroky v porovnaní s výsledkami z minulých štyroch štvrťrokov.
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS Q/Q spoločností v sektore Health Care sektor na OTC v porovnaní so spoločnosťou ProMIS Neurosciences
Čomu sa venuje spoločnosť ProMIS Neurosciences?
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Firmy s metrikou eps q/q podobnou spoločnosti ProMIS Neurosciences
- Hodnota metriky EPS Q/Q spoločnosti Alleghany je -0.63%
- Hodnota metriky EPS Q/Q spoločnosti Celanese Corp je -0.60%
- Hodnota metriky EPS Q/Q spoločnosti Walmart Inc je -0.56%
- Hodnota metriky EPS Q/Q spoločnosti M.D.C je -0.50%
- Hodnota metriky EPS Q/Q spoločnosti Bristol-Myers Squibb Co je -0.50%
- Hodnota metriky EPS Q/Q spoločnosti National Bank of Canada je -0.42%
- Hodnota metriky EPS Q/Q spoločnosti ProMIS Neurosciences je 0.00%
- Hodnota metriky EPS Q/Q spoločnosti ASML NV je 0.70%
- Hodnota metriky EPS Q/Q spoločnosti Zebra Technologies je 0.88%
- Hodnota metriky EPS Q/Q spoločnosti GATX je 0.90%
- Hodnota metriky EPS Q/Q spoločnosti Washington Trust je 0.93%
- Hodnota metriky EPS Q/Q spoločnosti Raymond James je 0.97%
- Hodnota metriky EPS Q/Q spoločnosti ePlus Inc je 1.02%